Akshay Vaishnaw
Director/Board Member at SCHOLAR ROCK HOLDING CORPORATION
Net worth: 4 M $ as of 31/03/2024
Profile
Dr. Akshay K. Vaishnaw is an Independent Director at Scholar Rock Holding Corp., an Independent Director at Editas Medicine, Inc., a President-Research & Development at Alnylam Pharmaceuticals, Inc. and a Member at The Royal College of Physicians. He is on the Board of Directors at Scholar Rock Holding Corp., Scholar Rock, Inc. and Editas Medicine, Inc. Dr. Vaishnaw was previously employed as a Senior Director-Translational Medicine by Biogen Idec, Inc. He also served on the board at Visterra, Inc. He received his undergraduate degree from the University of Cardiff, a doctorate degree from Cardiff University School of Medicine and a doctorate degree from the University of London.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/01/2024 | 23,289 ( 0.02% ) | 3 M $ | 31/03/2024 | |
| 21/06/2023 | 9,455 ( 0.01% ) | 167 921 $ | 31/03/2024 | |
EDITAS MEDICINE, INC.
-.--% | 01/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Akshay Vaishnaw active positions
| Companies | Position | Start |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02/10/2023 |
| EDITAS MEDICINE, INC. | Director/Board Member | 28/07/2016 |
| SCHOLAR ROCK HOLDING CORPORATION | Director/Board Member | 21/05/2019 |
| The Royal College of Physicians | Corporate Officer/Principal | 07/07/2009 |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Director/Board Member | 01/05/2019 |
Former positions of Akshay Vaishnaw
| Companies | Position | End |
|---|---|---|
| VISTERRA INC | Director/Board Member | 01/07/2018 |
| BIOGEN INC. | Corporate Officer/Principal | 01/01/2005 |
Training of Akshay Vaishnaw
| University of London | Doctorate Degree |
| University of Cardiff | Undergraduate Degree |
| Cardiff University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| BIOGEN INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| EDITAS MEDICINE, INC. | Health Technology |
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Akshay Vaishnaw
